Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus

Overview of attention for article published in Drug Safety, October 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 84 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,327 followers.

【総説】2型糖尿病の治療のためのアログリプチンのベネフィット・リスク評価（全文フリー） https://t.co/Uig7uZzkeM

Reply Repost Favourite